Hoppenot C, et al. - Researchers performed this review to assess the clinical and genomic features that have been associated with long-term survival in high grade serous ovarian cancer. They identified long-term survivors of advanced-stage epithelial ovarian cancer as a heterogeneous group. To predict long-term survival, clinical and pathologic factors seemed insufficient. It seems that models based on differential gene expression can classify long-term survivors.